ELV
Elevance Health Inc
386.40$
+1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.4% | 17.4% | 17.3% | 17.6% | 17.3% | 18.3% | 19.3% | 20.1% | 19.0% | 20.4% | 53.3% | 53.1% | |
| 9.9% | 6.0% | 5.6% | 5.8% | 6.8% | 7.1% | 6.3% | 7.0% | 7.1% | 7.8% | 7.7% | 8.1% | |
| 9.9% | 6.0% | 5.6% | 5.8% | 6.8% | 7.1% | 6.3% | 7.0% | 7.1% | 7.8% | 28.3% | 29.7% | |
| 10.5% | 11.4% | 11.8% | 11.8% | 10.6% | 11.2% | 13.0% | 13.1% | 11.9% | 12.5% | 18.1% | 18.5% | |
| -32.3% | -49.6% | -48.3% | -15.6% | -9.6% | – | – | – | – | – | – | – | |
| 3.8% | – | – | – | – | 4.5% | 3.9% | 3.8% | 3.8% | 3.9% | – | – | |
| 22.9% | 23.2% | 23.2% | 23.0% | 22.3% | 24.2% | 23.7% | 23.3% | 23.2% | 23.3% | 22.5% | 22.4% | |
| 9.5% | 9.4% | 9.6% | 9.2% | 8.9% | 10.3% | 10.0% | 9.4% | 9.2% | 9.2% | 8.8% | 8.7% | |
| 65.1% | 63.8% | 63.6% | 62.6% | 62.3% | 64.6% | 64.4% | 64.0% | 64.1% | 63.8% | 65.0% | 64.4% | |
| 19.4% | 17.9% | 20.0% | 17.5% | 16.8% | 16.6% | 17.0% | 17.0% | 14.7% | 16.4% | 36.0% | 25.9% | |
| 0.9% | 1.9% | 4.0% | 2.8% | 2.1% | 1.9% | 1.6% | 1.6% | 0.8% | 1.1% | 0.6% | 0.3% | |
| 14.6% | 14.8% | 14.7% | 13.5% | 13.2% | 13.5% | 14.0% | 14.1% | 14.0% | 14.1% | 4.9% | 19.8% | |
| 21.8% | 21.3% | 19.6% | 21.7% | 21.2% | 25.0% | 23.5% | 23.1% | 25.4% | 25.3% | 24.5% | 24.3% | |
| 34.8% | 36.1% | 36.3% | 37.3% | 37.6% | 35.3% | 35.5% | 35.9% | 35.8% | 36.1% | 34.9% | 35.5% | |
| 29.1% | 29.1% | 29.6% | 30.6% | 30.2% | 28.7% | 28.9% | 29.2% | 29.0% | 29.1% | 28.4% | 29.0% | |
| 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.